Cetera Trust Company’s Boston Scientific BSX Stock Holding History

Cetera Trust Company’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46.8K	Hold	746	–	–	0.03%	221
2025 Q4	$71.1K	Hold	746	–	–	0.04%	208
2025 Q3	$72.8K	Hold	746	–	–	0.04%	211
2025 Q2	$80.1K	Hold	746	–	–	0.05%	210
2025 Q1	$75.3K	Hold	746	–	–	0.05%	209
2024 Q4	$66.6K	Hold	746	–	–	0.04%	210
2024 Q3	$62.5K	Hold	746	–	–	0.04%	224
2024 Q2	$57.4K	Hold	746	–	–	0.04%	222
2024 Q1	$51.1K	Hold	746	–	–	0.03%	230
2023 Q4	$43.1K	Buy	+746	New	+$39.8K	0.03%	233

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Trust Company's BSX Position: Q1 2026 in Review

Cetera Trust Company held its Boston Scientific (BSX) position steady in Q1 2026 at 746 shares worth $46.8K. The position accounts for 0.03% of the portfolio, ranked #221.

Cetera Trust Company first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $80.1K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Cetera Trust Company held 746 shares of Boston Scientific worth $46.8K as of Q1 2026.
Cetera Trust Company left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.03% of Cetera Trust Company's portfolio in Q1 2026, its #221 holding.
Cetera Trust Company first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Cetera Trust Company's Boston Scientific position peaked at $80.1K in Q2 2025.
1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.